TORONTO, Oct. 02, 2026 (GLOBE NEWSWIRE) — Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) reported on its capital markets activity for the previous quarter, including activity under its at-the-market equity program (“ATM”) and equity participation by employees and directors.
Originally published via Source Article.
TORONTO, Oct. 02, 2026 (GLOBE NEWSWIRE) — Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) reported on its capital markets activity for the previous quarter, including activity under its at-the-market equity program (“ATM”) and equity participation by employees and directors.
Originally published via Source Article.
TORONTO, Oct. 02, 2026 (GLOBE NEWSWIRE) — BULGOLD Inc. (TSXV:ZLTO) (the “Company” or “BULGOLD”) is pleased to announce that it has engaged HE Capital Markets Ltd (“HECM”) to provide investor engagement services across North America and Europe.
VANCOUVER, British Columbia, Oct. 01, 2026 (GLOBE NEWSWIRE) — Hypercharge Networks Corp. (TSXV: HC; OTC: HCNWF; FSE: PB7) (the “Company” or “Hypercharge”), a leading EV charging operator, is pleased to announce, further to its news releases dated September 11 and September 28, 2026, that it has completed its previously announced acquisition of 100% of the equity interests of REVS Charging LLC (“REVS“) (the “Transaction”) following receipt of the acceptance of the TSX Venture Exchange (the “TSXV“). In connection with the closing of the Transaction, the Company has issued REVS, 18,000,000 common shares (the “Closing Shares”), subject to a six-month voluntary lockup (the “Lockup”).
Originally published via Source Article.
TORONTO, Oct. 01, 2026 (GLOBE NEWSWIRE) — Osisko Gold Group Inc. (NYSE: OGG, TSXV: OGG) (“Osisko Gold” or the “Company“) announces that, further to its August 25, 2026, announcement regarding the Company’s planned leadership succession transition, Elijah Tyshynski has assumed the role of Chief Financial Officer of the Company effective October 1, 2026, succeeding Alexander Dann.
Originally published via Source Article.
SASKATOON, Saskatchewan, Oct. 01, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX), a Canadian pharmacy acquisition and ownership platform, announced today that, further to its August 18, 2026, news release, it has completed the acquisition of a 100 per cent interest in a PharmaChoice Canada-bannered pharmacy located in Western Canada (the “Pharmacy Acquisition”), pursuant to the previously disclosed share purchase agreement dated August 10, 2026.
Originally published via Source Article.
TORONTO, Oct. 01, 2026 (GLOBE NEWSWIRE) — Osisko Gold Group Inc. (NYSE: OGG, TSXV: OGG) (“Osisko Gold” or the “Company“) announces that, further to its August 25, 2026, announcement regarding the Company’s planned leadership succession transition, Elijah Tyshynski has assumed the role of Chief Financial Officer of the Company effective October 1, 2026, succeeding Alexander Dann.
Originally published via Source Article.
TORONTO, Oct. 01, 2026 (GLOBE NEWSWIRE) — Osisko Gold Group Inc. (NYSE: OGG, TSXV: OGG) (“Osisko Gold” or the “Company“) announces that, further to its August 25, 2026, announcement regarding the Company’s planned leadership succession transition, Elijah Tyshynski has assumed the role of Chief Financial Officer of the Company effective October 1, 2026, succeeding Alexander Dann.
Originally published via Source Article.
SASKATOON, Saskatchewan, Oct. 01, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX), a Canadian pharmacy acquisition and ownership platform, announced today that, further to its August 18, 2026, news release, it has completed the acquisition of a 100 per cent interest in a PharmaChoice Canada-bannered pharmacy located in Western Canada (the “Pharmacy Acquisition”), pursuant to the previously disclosed share purchase agreement dated August 10, 2026.
Originally published via Source Article.
SASKATOON, Saskatchewan, Oct. 01, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX), a Canadian pharmacy acquisition and ownership platform, announced today that, further to its August 18, 2026, news release, it has completed the acquisition of a 100 per cent interest in a PharmaChoice Canada-bannered pharmacy located in Western Canada (the “Pharmacy Acquisition”), pursuant to the previously disclosed share purchase agreement dated August 10, 2026.
Originally published via Source Article.
